Other studies that reported a decrease in IR employed silymarin combined with B. aristata to treat patients with T2DM simultaneously with insulin/metformin/incretins/sulfonylureas/glitazones [66] or without standard treatment for T2DM but with a hypocaloric diet and physical activity [68]. The gene discussed is INS; the disease is type 2 diabetes mellitus.